PBSV (Pharma-Bio Serv) Retained Earnings: $9.08 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PBSV Pharma-Bio Serv Inc PBSV
43 GF Score
Price $0.42
GF Value $0.58
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pharma-Bio Serv Retained Earnings?

Pharma-Bio Serv PBSV -27.16% 43 Retained Earnings is $9.08 Mil as of Apr. 2026. GuruFocus rates PBSV with a GF Score™ of 43/100 and a GF Value™ of $0.58 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Pharma-Bio Serv's retained earnings for the quarter that ended in Apr. 2026 was $9.08 Mil.

Pharma-Bio Serv's quarterly retained earnings declined from Oct. 2025 ($10.53 Mil) to Jan. 2026 ($8.85 Mil) but then increased from Jan. 2026 ($8.85 Mil) to Apr. 2026 ($9.08 Mil).

Pharma-Bio Serv's annual retained earnings declined from Oct. 2023 ($14.85 Mil) to Oct. 2024 ($12.35 Mil) and declined from Oct. 2024 ($12.35 Mil) to Oct. 2025 ($10.53 Mil).


Pharma-Bio Serv  (OTCPK:PBSV) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Pharma-Bio Serv Retained Earnings Historical Data

* Premium members only.

The historical data trend for Pharma-Bio Serv's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma-Bio Serv Retained Earnings Chart

Pharma-Bio Serv Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.71 15.27 14.85 12.35 10.53

Pharma-Bio Serv Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.74 10.53 10.53 8.85 9.08
PBSV
43GF Score
Pharma-Bio Serv Inc PBSV
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma-Bio Serv Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $9.08 Mil mean?
Pharma-Bio Serv (PBSV) has a Retained Earnings of $9.08 Mil as of Apr. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Pharma-Bio Serv and its competitors.
Is Pharma-Bio Serv's Retained Earnings too high?
Pharma-Bio Serv's current Retained Earnings is $9.08 Mil. Overall, Pharma-Bio Serv has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma-Bio Serv's Retained Earnings compare to MGRX and BFRG?
Pharma-Bio Serv's Retained Earnings of $9.08 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Pharma-Bio Serv and its competitors. Pharma-Bio Serv's current Retained Earnings is $9.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma-Bio Serv stock overvalued right now?
Based on GuruFocus' analysis, Pharma-Bio Serv (PBSV) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.58, compared to a current price of $0.42 — trading 27.2% below its estimated fair value. The current Retained Earnings is $9.08 Mil. Pharma-Bio Serv's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Pharma-Bio Serv (PBSV), the current Retained Earnings is $9.08 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma-Bio Serv (PBSV) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma-Bio Serv stock appears to be undervalued. The current stock price of $0.42 is trading 27.2% below its estimated GF Value™ of $0.58. GuruFocus considers Pharma-Bio Serv to be Modestly Undervalued.

Key valuation signals for PBSV:

  • Retained Earnings: $9.08 Mil
  • GF Value™: $0.58 vs. price of $0.42 (27.2% below fair value)
  • GF Score™: 43/100 with 1 warning sign

No single metric tells the full story. See the PBSV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma-Bio Serv Business Description

Address No. 6 Road 696, Pharma-Bio Serv Building, Dorado, PRI, 00646
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.
43GF Score

Get the complete analysis for PBSV

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.58
GF Value